Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Multiple Myeloma 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 5fludarabine 3pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1fiu protein, E coli 1Vincristine 1Surveys and Questionnaires 1Sugars 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Methotrexate 1Melphalan 1Loratadine 1Etoposide 1Doxorubicin 1Cholestanetriol 26-Monooxygenase 1CVAD protocol 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Burkitt Lymphoma × Cholestanetriol 26-Monooxygenase × Clear all
NCT04626726 2020-11-13

Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation

Hebei Senlang Biotechnology Inc., Ltd.

Phase EARLY_PHASE1 Unknown
50 enrolled
Lymphoid

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡